Clinical Trial Update: A Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP3086S in Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 1]

View source ↗

Summary

This completed Phase 1 trial evaluated the safety and pharmacokinetics of escalating doses of DSTP3086S in patients with metastatic castration-resistant prostat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• DSTP3086S (DSTP3086S)

Snippet

Sponsor: Genentech, Inc. | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED